1d5dd22096a94397928fbaa184f9c5542a12e9844a7b4e36a067a0d15ac8820c2b2dc91e73a24beba3329f557622ebb6584ffa938cb14355b92117e676c25ab06046b92ee06445298c6c54b4ea518b59874af62534f9469682a082c610c49074944948625cde4b07bebc7497bd2025219fd0deccb3264fe7bdef0bfcf32979efa1efe92266fc49589b421125241b4c9ab0ee973e3e7a4ebcbb83be344937d0dabcf590c8f3ba45308e9e7faafad8e941c2d9db5ac2244b05915fea59d828b9bbc99bd797450f4f27917cf04c8e48a777f4d801397e7d42bda0d0446c5660bb3c
agent
Meta-analysis of Genome-Wide Association Studies Identifies Novel Loci Associated With Optic Disc MorphologyWhole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's MembraneGenetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populationsNew insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristicsPrevalence of Age-Related Macular Degeneration in Europe: The Past and the FutureFive-year progression of unilateral age-related macular degeneration to bilateral involvementAntiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trialEnlargement of Geographic Atrophy From First Diagnosis to End of LifeHarmonizing the classification of age-related macular degeneration in the three-continent AMD consortiumEpidemiology of Reticular Pseudodrusen in Age-Related Macular DegenerationPredicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine LearningLipids, lipid genes, and incident age-related macular degenerationComparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular EdemaComparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study
author
nationality
type
label
Johannes R Vingerling
firstName
Johannes R
lastName
Vingerling